Aktie 002007 HUALAN BIOLOGICAL ENGINEERING INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Hualan Biological Engineering Inc.

Aktien

002007

CNE000001JN8

002007

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 25.04.2024 		% 5 Tage % 1. Jan.
19.04 CNY -0.26% Intraday Chart für Hualan Biological Engineering Inc. +0.58% -13.96%
25.04. Hualan Biological Engineering Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
02.04. Gewinn von Hualan Biological Engineering steigt um 38%; übertrifft EPS- und Umsatzschätzungen MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Hualan Biological Engineering's Profit Rises 38%; Tops EPS, Revenue Estimates
Hualan Biological Engineering Inc. Proposes Profit Distribution for 2023
Hualan Biological Engineering Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Hualan Biological Engineering Obtains Blood Collection License
Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Hualan Biological Engineering's Plasma Station Gets Permit to Collect Blood
Hualan Biological Engineering's Unit Gets Nod to Trial Antibody Injection
Hualan Biological Engineering Inc. Announces Final Dividend on Share A for 2022, Payable on June 14, 2023
Hualan Biological Engineering Obtains Blood Plasma Collection License
Hualan Biological Engineering's Unit Gets Nod for Trial of Tumor Drug
Hualan Biological Engineering Inc. Approves Cash Dividend for 2022
Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Hualan Biological Engineering Inc. Proposes Final Dividend for 2022
Hualan Biological Bacterin Registers Freeze-Dried Human Rabies Vaccine
Hualan Biological Engineering Wins Approval to Build Apheresis Stations
Hualan Biological to Sell Assets to Joint Stock Company for $27 Million
Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
China's Sept factory activity set for third straight monthly contraction:Reuters poll
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 002007 Aktie
  4. Nachrichten Hualan Biological Engineering Inc.
  5. Andere Sprachen